GR910100067A - Αναστολείς αρωματάσης. - Google Patents

Αναστολείς αρωματάσης.

Info

Publication number
GR910100067A
GR910100067A GR910100067A GR910100067A GR910100067A GR 910100067 A GR910100067 A GR 910100067A GR 910100067 A GR910100067 A GR 910100067A GR 910100067 A GR910100067 A GR 910100067A GR 910100067 A GR910100067 A GR 910100067A
Authority
GR
Greece
Prior art keywords
aromatase inhibitors
compounds
aromatase
androstenodione
androstanodione
Prior art date
Application number
GR910100067A
Other languages
Greek (el)
English (en)
Inventor
Fernard Labrie
Merand Yves
Original Assignee
Endorecherche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorecherche Inc filed Critical Endorecherche Inc
Publication of GR910100067A publication Critical patent/GR910100067A/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR910100067A 1990-02-08 1991-02-07 Αναστολείς αρωματάσης. GR910100067A (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/477,024 US5227375A (en) 1990-02-08 1990-02-08 Aromatase inhibitors

Publications (1)

Publication Number Publication Date
GR910100067A true GR910100067A (el) 1992-06-30

Family

ID=23894189

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910100067A GR910100067A (el) 1990-02-08 1991-02-07 Αναστολείς αρωματάσης.

Country Status (10)

Country Link
US (1) US5227375A (enExample)
AU (1) AU7150991A (enExample)
GR (1) GR910100067A (enExample)
IE (1) IE65269B1 (enExample)
IL (1) IL97122A (enExample)
MY (1) MY105479A (enExample)
NZ (1) NZ236966A (enExample)
TW (1) TW221418B (enExample)
WO (1) WO1991012206A2 (enExample)
ZA (1) ZA91604B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017489A1 (fr) * 1991-03-28 1992-10-15 Teikoku Hormone Mfg. Co., Ltd. Nouveau derive oxa- ou azasteroide
DE69324595T2 (de) * 1992-09-30 1999-08-19 Teikoku Hormone Mfg. Co. 7-substituierte oxa-steroid verbindung
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US5593987A (en) * 1993-12-21 1997-01-14 Eli Lilly And Company Methods of inhibiting breast disorders
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6117429A (en) * 1997-08-11 2000-09-12 Weider Nutrition International, Inc Compositions and treatments for reducing potential unwanted side effects associated with long-term administration of androgenic testosterone precursors
MXPA00008868A (es) 1998-03-11 2003-04-25 Endorech Inc Inhibidores de dihidrogenasa de 17 -hidroxiesteroide y metodos para su uso.
EP1219631A4 (en) * 1999-08-23 2003-03-19 Chugai Pharmaceutical Co Ltd ANTIANDROGEN ACTIVE SUBSTANCES
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
TW200401781A (en) * 2002-03-22 2004-02-01 Pharmacia Corp C-17 spirolactonization and 6, 7 oxidation of steroids
RU2004131523A (ru) * 2002-03-22 2005-06-10 Фармация Корпорейшн (Us) С-17-спиролактонизация и 6,7-окисление стероидов
PL376896A1 (pl) * 2002-11-07 2006-01-09 Pharmacia & Upjohn Company Llc Sposoby wytwarzania 5-androstenów podstawionych w pozycji C-7
EP1709062B9 (en) 2004-01-16 2013-02-13 Cedarburg Pharmaceuticals, Inc. Exemestane and its intermediates and methods of making the same
BR112012029392A2 (pt) * 2010-05-20 2017-07-11 Univ Saskatchewan uso d einibidores de aromatase para a sincronização da ovulação, indução da superovulação ou ovulação dupla e melhora da geminação e fertilidade em um mamífero
US10004723B2 (en) 2013-04-19 2018-06-26 University Of Saskatchewan Aromatase inhibitor-releasing intravaginal device

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952018A (en) * 1972-01-14 1976-04-20 Hoffmann-La Roche Inc. 15-Oxasteroids
DE2558088A1 (de) * 1975-12-19 1977-07-07 Schering Ag Verfahren zur herstellung von 4-androsten-3,17-dion-derivaten
EP0115965A2 (en) * 1983-02-09 1984-08-15 The Upjohn Company Process for converting 17-keto-steroids to 16-beta-methyl-17-keto-steroids
US4596797A (en) * 1981-05-22 1986-06-24 Schering Aktiengesellschaft Use of aromatase-inhibitors for prophylaxis and/or treatment of benign prostatic hyperplasia
DE3612632A1 (de) * 1986-04-11 1987-10-22 Schering Ag Verfahren zur herstellung von 7(alpha)-propylsteroiden
US4822528A (en) * 1986-09-17 1989-04-18 Farmitalia Carlo Erba S.R.L. 4-substituted 6-alkylidenandrosteine-3,17-dione derivatives and process for their preparation
US4824830A (en) * 1986-07-14 1989-04-25 Farmitalia Carlo Erba S.R.L. 6- or 7-methylenandrosta-1,4-diene-3,17-dione derivatives and process for their preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125071C (enExample) * 1963-12-24
US3380886A (en) * 1965-04-07 1968-04-30 Upjohn Co 7alpha-methyl-3beta-hydroxy-5-androstenes
US3591607A (en) * 1966-04-19 1971-07-06 Hoffmann La Roche Retrosteroid a-ring formation
US3766213A (en) * 1966-04-19 1973-10-16 Hoffmann La Roche Retrosteroid a ring formation
US3485828A (en) * 1967-04-10 1969-12-23 Syntex Corp 6,7-ethylene and 6,7-substituted ethylene derivatives of the pregnane series
US4596796A (en) * 1983-09-12 1986-06-24 Sumitomo Chemical Company, Limited Dithiolphosphoric acid ester as a soil pesticide

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952018A (en) * 1972-01-14 1976-04-20 Hoffmann-La Roche Inc. 15-Oxasteroids
DE2558088A1 (de) * 1975-12-19 1977-07-07 Schering Ag Verfahren zur herstellung von 4-androsten-3,17-dion-derivaten
US4596797A (en) * 1981-05-22 1986-06-24 Schering Aktiengesellschaft Use of aromatase-inhibitors for prophylaxis and/or treatment of benign prostatic hyperplasia
EP0115965A2 (en) * 1983-02-09 1984-08-15 The Upjohn Company Process for converting 17-keto-steroids to 16-beta-methyl-17-keto-steroids
DE3612632A1 (de) * 1986-04-11 1987-10-22 Schering Ag Verfahren zur herstellung von 7(alpha)-propylsteroiden
US4824830A (en) * 1986-07-14 1989-04-25 Farmitalia Carlo Erba S.R.L. 6- or 7-methylenandrosta-1,4-diene-3,17-dione derivatives and process for their preparation
US4822528A (en) * 1986-09-17 1989-04-18 Farmitalia Carlo Erba S.R.L. 4-substituted 6-alkylidenandrosteine-3,17-dione derivatives and process for their preparation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, vol. 30, March 1989, page 303, abstract 1206 "Endocrinology" *
STEROIDS, vol. 40, no. 6, December 1982, page 603; A.J. Solo et al.: "7alpha-alkyltestosterone derivatives: synthesis and activity as androgens and as aromatase inhibitors" *

Also Published As

Publication number Publication date
WO1991012206A2 (en) 1991-08-22
ZA91604B (en) 1992-09-30
MY105479A (en) 1994-10-31
IL97122A (en) 1996-06-18
WO1991012206A3 (en) 1991-11-28
NZ236966A (en) 1993-11-25
AU7150991A (en) 1991-09-03
TW221418B (enExample) 1994-03-01
US5227375A (en) 1993-07-13
IE910263A1 (en) 1991-08-14
IL97122A0 (en) 1992-05-25
IE65269B1 (en) 1995-10-18

Similar Documents

Publication Publication Date Title
GR910100067A (el) Αναστολείς αρωματάσης.
MY106315A (en) Pharmaceutical agents
ES2160707T3 (es) Composiciones que comprenden agentes deteriorantes del adn y p53.
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
FI951454A0 (fi) 1-(2-oksoasetyyli)piperidiini-2-karboksyylihappojohdannaiset monille lääkkeille resistenttien syöpäsolujen herkistäjinä
NO955256L (no) Fenylheterosykluser som syklooksygenase-2-inhibitorer
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
DE69922676D1 (de) N-aralkylaminotetraline als neuropeptid-y-y5-rezeptorliganden
DE69918296D1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
DE69825603D1 (de) 2,3,5-trisubstituierte pyridine als inhibitoren von cyclooxygenase-2
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
NO20020282D0 (no) Nytt difenylpiperidinderivat
NO20051404L (no) Pyridylsubstituerte heterocykluser som er nyttige for behandling eller forebyggelse av HCV infeksjon
ES2182035T3 (es) Derivados del bisarilciclobuteno como inhibidores de ciclooxigenasa.
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
WO2000078795A3 (en) Rufomycins and derivatives thereof useful as inhibitors of multi-drug resistance associated protein-1 (mrp-1)
DE69717843D1 (de) Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
NO970573D0 (no) Ylidenforbindelser og deres fremstilling